Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects CURRENT DRUG SAFETY DeBattista, C., DeBattista, K. 2010; 5 (3): 263–66

View details for DOI 10.2174/157488610791698325

View details for Web of Science ID 000218277000011